News

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
Noom will start offering smaller doses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health ...
Key research pitching the drugs against each other found Mounjaro was superior when it came to shedding pounds and losing ...
On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...
In the near term, commercial efforts might raise the chances that new patients are prescribed Novo Nordisk’s drug, assuming ...
SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, ...
More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications ...
Novo Nordisk ( NVO 1.82%) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...